StonvexLoading…
StonvexStonvexStonvexCore line items from DERM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.92M | $61.24M | $45.17M | $28.15M |
Operating Income | $-1.49M | $-8.17M | $-7.73M | $-6.20M |
Net Income | $-2.23M | $-11.43M | $-10.18M | $-7.87M |
EPS (Diluted) | $-0.08 | $-0.47 | $-0.43 | $-0.34 |
Total Assets | $91.53M | $94.59M | $85.19M | $81.16M |
Total Liabilities | $60.70M | $62.74M | $59.29M | $61.91M |
Cash & Equivalents | $27.22M | $24.09M | $24.95M | $20.29M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 27.31M | 24.50M | 23.63M | 22.95M |